| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.7M | +21.8% |
| R&D Expense | $326.2M | +15.2% |
| SG&A Expense | $227.7M | +24.1% |
| Operating Income | -$547.0M | -18.7% |
| Pre-tax Income | -$532.8M | -16.4% |
| Net Income | -$532.8M | -16.4% |
| EPS (Basic) | -$8.98 | -15.1% |
| EPS (Diluted) | -$8.98 | -15.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $162.7M | -44.7% |
| Short-term Investments | $1.11B | -23.4% |
| Current Assets | $1.34B | -25.7% |
| Total Assets | $1.36B | -25.7% |
| Current Liabilities | $99.3M | +16.5% |
| Total Liabilities | $103.8M | +7.9% |
| Stockholders' Equity | $1.25B | -27.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$460.0M | -21.6% |
| Capital Expenditures | $937K | +151.9% |
| Investing Cash Flow | $325.4M | +132.5% |
| Financing Cash Flow | $3.1M | -77.0% |
| Free Cash Flow | -$461.0M | -21.8% |